Primary |
Asthma |
33.8% |
Product Used For Unknown Indication |
11.5% |
Multiple Allergies |
8.1% |
Drug Use For Unknown Indication |
6.8% |
Rhinitis Allergic |
5.7% |
Chronic Obstructive Pulmonary Disease |
5.0% |
Hiv Infection |
4.5% |
Nasal Congestion |
3.7% |
Seasonal Allergy |
3.5% |
Hypersensitivity |
3.3% |
Sinusitis |
2.9% |
Sinus Disorder |
1.9% |
Hypertension |
1.8% |
Rhinitis |
1.5% |
Pain |
1.1% |
Upper-airway Cough Syndrome |
1.1% |
Cough |
1.1% |
Sinus Congestion |
1.0% |
Blood Pressure |
0.8% |
Bronchitis |
0.8% |
|
Drug Ineffective |
22.2% |
Pharmaceutical Product Complaint |
10.2% |
Product Quality Issue |
7.5% |
Anosmia |
6.9% |
Epistaxis |
6.1% |
Headache |
5.5% |
Asthma |
4.5% |
Dyspnoea |
4.3% |
Vision Blurred |
3.9% |
Vomiting |
3.7% |
Weight Increased |
3.0% |
Cough |
2.8% |
Nasal Congestion |
2.8% |
Sinusitis |
2.6% |
Therapeutic Response Unexpected With Drug Substitution |
2.6% |
Pneumonia |
2.4% |
Wheezing |
2.4% |
Nasal Discomfort |
2.2% |
Product Substitution Issue |
2.2% |
Sinus Disorder |
2.0% |
|
Secondary |
Asthma |
31.7% |
Drug Use For Unknown Indication |
14.7% |
Product Used For Unknown Indication |
12.7% |
Chronic Obstructive Pulmonary Disease |
5.2% |
Hiv Infection |
4.9% |
Hypertension |
4.5% |
Pain |
3.7% |
Foetal Exposure During Pregnancy |
3.6% |
Sinus Disorder |
2.3% |
Hypersensitivity |
2.2% |
Rhinitis Allergic |
2.1% |
Bronchitis |
1.6% |
Gastrooesophageal Reflux Disease |
1.6% |
Depression |
1.6% |
Nasal Congestion |
1.5% |
Blood Pressure Increased |
1.4% |
Cardiac Disorder |
1.2% |
Blood Cholesterol Increased |
1.2% |
Cough |
1.2% |
Multiple Allergies |
1.2% |
|
Adrenal Insufficiency |
16.5% |
Drug Ineffective |
12.8% |
Wheezing |
8.5% |
Fibromyalgia |
8.0% |
Asthma |
5.9% |
Osteonecrosis |
5.9% |
Anosmia |
4.3% |
Vomiting |
4.3% |
Speech Disorder |
3.7% |
Pharmaceutical Product Complaint |
3.2% |
Pneumonia |
3.2% |
Drug Exposure During Pregnancy |
2.7% |
Dysphonia |
2.7% |
Dyspnoea |
2.7% |
Headache |
2.7% |
Nausea |
2.7% |
Rhinorrhoea |
2.7% |
Rotator Cuff Syndrome |
2.7% |
Secondary Adrenocortical Insufficiency |
2.7% |
Tendonitis |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
31.0% |
Drug Use For Unknown Indication |
18.0% |
Asthma |
13.4% |
Hypertension |
4.6% |
Chronic Obstructive Pulmonary Disease |
4.5% |
Rheumatoid Arthritis |
4.1% |
Pain |
3.6% |
Hypersensitivity |
2.7% |
Depression |
2.1% |
Gastrooesophageal Reflux Disease |
2.1% |
Osteoporosis |
2.0% |
Anxiety |
1.5% |
Diabetes Mellitus |
1.5% |
Contraception |
1.4% |
Blood Cholesterol Increased |
1.3% |
Hiv Infection |
1.3% |
Crohn's Disease |
1.3% |
Prophylaxis |
1.3% |
Vitamin Supplementation |
1.2% |
Insomnia |
1.2% |
|
Vomiting |
9.0% |
Dyspnoea |
8.9% |
Weight Decreased |
7.3% |
Pain |
6.1% |
Pneumonia |
5.9% |
Drug Ineffective |
5.4% |
Urticaria |
5.2% |
Death |
5.1% |
Pyrexia |
4.6% |
Wheezing |
4.5% |
Asthma |
4.4% |
Pulmonary Embolism |
4.2% |
Sepsis |
4.2% |
Rash |
4.0% |
Oedema Peripheral |
3.7% |
Tremor |
3.7% |
Pain In Extremity |
3.6% |
Pruritus |
3.6% |
Nausea |
3.3% |
Weight Increased |
3.3% |
|
Interacting |
Hiv Infection |
32.5% |
Cystic Fibrosis |
11.9% |
Asthma |
9.1% |
Bronchitis Chronic |
8.3% |
Product Used For Unknown Indication |
7.1% |
Pain |
3.6% |
Diabetes Mellitus Non-insulin-dependent |
3.2% |
Drug Use For Unknown Indication |
3.2% |
Bronchospasm |
2.4% |
Essential Hypertension |
2.4% |
Hiv Infection Cdc Category A1 |
2.4% |
Oral Candidiasis |
2.4% |
Dyspnoea |
2.0% |
Bronchiectasis |
1.6% |
Depression |
1.6% |
Respiratory Tract Infection |
1.6% |
Anxiety |
1.2% |
Gastrooesophageal Reflux Disease |
1.2% |
Hypercholesterolaemia |
1.2% |
Hypertension |
1.2% |
|
Secondary Adrenocortical Insufficiency |
18.8% |
Drug Interaction |
16.7% |
Weight Increased |
12.5% |
Myalgia |
8.3% |
Cushing's Syndrome |
6.3% |
Stomatitis |
6.3% |
Drug Withdrawal Syndrome |
4.2% |
Pituitary-dependent Cushing's Syndrome |
4.2% |
Respiratory Tract Infection |
4.2% |
Skin Striae |
4.2% |
Abasia |
2.1% |
Adrenal Suppression |
2.1% |
Chest Pain |
2.1% |
Peroneal Nerve Palsy |
2.1% |
Plasmablastic Lymphoma |
2.1% |
Rash |
2.1% |
Weight Decreased |
2.1% |
|